GIP RECEPTOR AGONISM IMPROVES DYSLIPIDEMIA AND ATHEROSCLEROSIS INDEPENDENTLY OF BODY WEIGHT LOSS IN PRECLINICAL MOUSE MODEL FOR CARDIO-METABOLIC DISEASE